Effect of TLR10 (2322A/G, 720A/C, and 992T/A) polymorphisms on the pathogenesis of Crimean Congo hemorrhagic fever disease

Journal of Medical Virology

Volumn 90, Issue 1, 2018, Pages 19-25

  Kızıldağ, Sibel ^a   Arslan, Serdal ^b   Özbilüm, Nil ^b   Engin, Aynur ^b   Bakır, Mehmet ^b  

^a YUZUNCU YIL UNIVERSITY   (Turkey)

^b CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Crimean Congo hemorrhagic fever virus; genetic polymorphism; TLR10

Indexed keywords

TOLL LIKE RECEPTOR 10; BIOLOGICAL MARKER; TLR10 PROTEIN, HUMAN;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA POLYMORPHISM; FATALITY; FEMALE; GENETIC ASSOCIATION STUDY; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RATE; PATHOGENESIS; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TLR10 GENE; TURK (PEOPLE); BLOOD; EPIDEMIOLOGY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MORTALITY; PATHOPHYSIOLOGY; PROCEDURES; SEVERITY OF ILLNESS INDEX;

ADULT; BIOMARKERS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; SEVERITY OF ILLNESS INDEX; TOLL-LIKE RECEPTOR 10; TURKEY;

EID: 85034093339     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.24924     Document Type: Article

References (44)

1. Leblebicioglu H. Crimean-Congo haemorrhagic fever in Eurasia. Int J Antimicrob Agents. 2010; 36: S43–S46
2. Hoogstraal H. The epidemiology of tick-borne Crimean-Congo hemorrhagic fever in Asia, Europe, and Africa. J Med Entomol. 1979; 15:307–417.
3. Ardalan MR, Tubbs RS, Chinikar S, Shoja MM. Crimean-Congo haemorrhagic fever presenting as thrombotic microangiopathy and acute renal failure. Nephrol Dial Transplant. 2006; 21:2304–2307.
4. Bergeron É, Albariño CG, Khristova ML, Nichol ST. Crimean-Congo hemorrhagic fever virus-encoded ovarian tumor protease activity is dispensable for virus RNA polymerase function. J Virol. 2010; 84:216–226.
5. Flick R, Flick K, Feldmann H, Elgh F. Reverse genetics for crimean-Congo hemorrhagic fever virus. J Virol. 2003; 77:5997–6006.
6. Chang ZL. Important aspects of Toll-like receptors, ligands and their signaling pathways. Inflamm Res. 2010; 59:791–808.
7. Kesar V, Odin JA. Toll-like receptors and liver disease. Liver Int. 2014; 34:184–196.
8. Chuang TH, Ulevitch RJ. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim Biophys Acta. 2001; 1518:157–161.
9. Hasan U, Chaffois C, Gaillard C, et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol. 2005; 174:2942–2950.
10. Guan Y, Ranoa DR, Jiang S, et al. Human TLRs 10 and 1 share common mechanisms of innate immune sensing but not signaling. J Immunol. 2010; 184:5094–5103.
11. Oosting M, Cheng SC, Bolscher JM, et al. Human TLR10 is an anti-inflammatory pattern-recognition receptor. Proc Natl Acad Sci USA. 2014; 111:4478–4484.
12. Willie B, Hall NB, Stein CM, et al. Association of Toll-like receptor polymorphisms with HIV status in North Americans. Genes Immun. 2014; 15:569–577.
13. Zayed RA, Omran D, Mokhtar DA, et al. Association of toll-Like receptor 3 and toll-Like receptor 9 single nucleotide polymorphisms with hepatitis C virus infection and hepatic fibrosis in egyptian patients. Am J Trop Med Hyg. 2017; 96:720–726.
14. Tongtawee T, Bartpho T, Kaewpitoon S, et al. Genetic polymorphisms in TLR1, TLR2, TLR4, and TLR10 of Helicobacter pylori-associated gastritis: a prospective cross-sectional study in Thailand. Eur J Cancer Prev. 2017; https://doi.org/10.1097/CEJ.0000000000000347.
15. Bulat-Kardum LJ, Etokebe GE, Lederer P, Balen S, Dembic Z. Genetic polymorphisms in the toll-like receptor 10, interleukin (IL)17A and IL17F genes differently affect the risk for tuberculosis in croatian population. Scand J Immunol. 2015; 82:63–69.
16. Cho WK, Jang JP, Choi EJ, Jeon YJ, Jung IA, Kim SH, Jung MH, Kim TG, Suh BK. Association of Toll-like receptor 10 polymorphisms with autoimmune thyroid disease in Korean children. Thyroid. 2015; 25:250–255.
17. Engin A, Arslan S, Özbilüm N, Bakir M. Is there any relationship between Toll-like receptor 3 c.1377C/T and—7C/A polymorphisms and susceptibility to Crimean Congo hemorrhagic fever? J Med Virol. 2016; 88:1690–1696.
18. Arslan S, Engin A, Özbilüm N, Bakır M. Toll-like receptor 7 Gln11Leu, c.4-151A/G, and +1817G/T polymorphisms in Crimean Congo hemorrhagic fever. J Med Virol. 2015; 87:1090–1095.
19. Engin A, Arslan S, Kizildag S, et al. Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever. Microbes Infect. 2010; 12:1071–1078.
20. Etem EO, Elyas H, Ozgocmen S, Yıldırım A, Godekmerdan A. The investigation of toll-like receptor 3, 9 and 10 gene polymorphisms in Turkish rheumatoid arthritis patients. Rheumatol Int. 2011; 31:1369–1374.
21. Lazarus R, Raby BA, Lange C, et al. TOLL-like receptor 10 genetic variations is associated with asthma in two independent samples. Am J Respir Crit Care Med. 2004; 170:594–600.
22. Park HJ, Hahn WH, Suh JS, et al. Association between toll-like receptor 10 (TLR10) gene polymorphisms and childhood IgA nephropathy. Eur J Pediatr. 2011; 170:503–509.
23. Nuolivirta K, Törmänen S, Teräsjärvi J, et al. Post-bronchiolitis wheezing is associated with toll-like receptor 9 rs187084 gene polymorphism. Sci Rep. 2016; 6:31165.
24. Guirado M, Gil H, Saenz-Lopez P, et al. Association between C13ORF31, NOD2, RIPK2 and TLR10 polymorphisms and urothelial bladder cancer. Hum Immunol. 2012; 73:668–672.
25. Xiao W, Liu Z, Lin J, et al. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease. Autoimmunity. 2015; 48:13–18.
26. Stevens VL, Hsing AW, Talbot JT, et al. Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. Int J Cancer. 2008; 123:2644–2650.
27. Mailaparambil B, Krueger M, Heinze J, Forster J, Heinzmann A. Polymorphisms of toll like receptors in the genetics of severe RSV associated diseases. Dis Markers. 2008; 25:59–65.
28. Chen YC, Giovannucci E, Kraft P, Lazarus R, Hunter DJ. Association between Toll-like receptor gene cluster (TLR6, TLR1, and TLR10) and prostate cancer. Cancer Epidemiol Biomarkers Prev. 2007; 16:1982–1989.
29. Netea MG, Van der Meer JW, Kullberg BJ. Toll-like receptors as an escape mechanism from the host defense. Trends Microbiol. 2004; 12:484–488.
30. Vaidya SA, Cheng G. Toll-like receptors and innate antiviral responses. Curr Opin Immunol. 2003; 15:402–407.
31. Abreu MT, Fukata M, Arditi M. TLR signaling in the gut in health and disease. J Immunol. 2005; 174:4453–4460.
32. Seki E, Brenner DA. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology. 2008; 48:322–335.
33. MohammadHosseini A, Majidi J, Baradaran B, Yousefi M. Toll- like receptors in the pathogenesis of autoimmune diseases. Adv Pharm Bull. 2015; 5:605–614.
34. O'Neill LA, Bowie AG. The family of five: tIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol. 2007; 7:353–364.
35. Elaldı N, Yilmaz M, Bagci B, et al. Relationship between IFNA1, IFNA5, IFNA10, and IFNA17 gene polymorphisms and Crimean-Congo hemorrhagic fever prognosis in a Turkish population range. J Med Virol. 2001; 88:1159–1167.
36. Arslan S, Engin A. Relationship between NF-κB1 and NF-κBIA genetic polymorphisms and Crimean-Congo hemorrhagic fever. Scand J Infect Did. 2012; 44:138–143.
37. Kaya S, Elaldi N, Kubar A, et al. Sequential determination of serum viral titers, virus-specific IgG antibodies, and TNF-α, IL-6, IL-10, and IFN-γ levels in patients with Crimean-Congo hemorrhagic fever. BMC Infect Dis. 2014; 14:416.
38. Yilmaz M, Elaldi N, Bagci B, Sari I, Gümüs E, Yelkovan I. Effect of tumour necrosis factor-alpha and interleukin-6 promoter polymorphisms on course of Crimean-Congo hemorrhagic fever in Turkish patients. J Vector Borne Dis. 2015; 52:30–35.
39. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006; 6:203–214.
40. Akıncı E, Bodur H, Leblebicioglu H. Pathogenesis of crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013; 13:429–437.
41. Feldmann H, Bugany H, Mahner F, Klenk HD, Drenckhahn D. Schnittler HJ. Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages. J Virol. 1996; 70:2208–2214.
42. Li X, Han X, Llano J, et al. Mammalian target of rapamycin inhibition in macrophages of asymptomatic HIV+ persons reverses the decrease in TLR-4-mediated TNF-α release through prolongation of MAPK pathway activation. J Immunol. 2011; 187:6052–6058.
43. Hess NJ, Felicelli C, Grage J, Tapping RI. TLR10 suppresses the activation and differentiation of monocytes with effects on DC-mediated adaptive immune responses. J Leukoc Biol. 2017; 101:1245–1252.
44. Jiang S, Li X, Hess NJ, Guan Y, T, Tapping RI. TLR10 is a negative regulator of both MyD88-dependent and −independent TLR signaling. J Immunol. 2016; 196:3834–3841.